Multiple sclerosis: Oligoclonal bands still yield clues about multiple sclerosis

Nature Reviews Neurology

Volumn 6, Issue 11, 2010, Pages 588-589

  Cross, Anne H ^a   Wu, Gregory F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BIOLOGICAL MARKER; GLATIRAMER; IMMUNOGLOBULIN G; INTERFERON BETA SERINE; NEUTRALIZING ANTIBODY; OLIGOCLONAL BAND;

ANTIBODY DETECTION; B LYMPHOCYTE; CELL SELECTION; CEREBROSPINAL FLUID; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; EARLY INTERVENTION; HUMAN; LYMPHOCYTE FUNCTION; MULTIPLE SCLEROSIS; NEUROIMAGING; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS; SHORT SURVEY; THERAPY EFFECT;

ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTES; BLOOD-BRAIN BARRIER; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-BETA; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OLIGOCLONAL BANDS; PROGNOSIS; TREATMENT OUTCOME;

EID: 78149377529     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.142     Document Type: Short Survey

References (10)

1. Lundkvist, M., Greiner, e., Hillert, J. & Fogdell-Hahn, A. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta. Mult. Scler. 16, 796-800 (2010).
2. Bosca, i. et al. Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal igM bands. Mult. Scler. 16, 810-815 (2010).
3. Garcia-Barragan, n. et al. Multiple sclerosis patients with anti-lipid oligoclonal igM show early favourable response to immunomodulatory treatment. Eur. J. Neurol. 16, 380-385 (2009).
4. Owens, G. P. et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann. Neurol. 65, 639-649 (2009).
5. Avasarala, J. R., Cross, A. H. & Trotter, J. L. Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch. Neurol. 58, 2044-2045 (2001).
6. Joseph, F. G. et al. CsF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients. J. Neurol. Neurosurg. Psychiatry 80, 292-296 (2009).
7. Hauser, s. L. et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358, 676-688 (2008).
8. Piccio, L. et al. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch. Neurol. 67, 707-714 (2010).
9. Bar-Or, A. et al. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in Ms? Ann. Neurol. 67, 452-461 (2010).
10. + influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol. Cell. Neurosci. 22, 14-24 (2003).